RSS Feed

Apple Podcasts

Overcast

Castro

Pocket Casts

English

Non-explicit

Business

Investing

spreaker.com

7:46

It looks like this podcast has ended some time ago. This means that no new episodes have been added some time ago. If you're the host of this podcast, you can check whether your RSS file is reachable for podcast clients.

Morgans Under the Microscope

by Morgans Financial Limited

A series of podcasts that include interviews with executives from ASX-listed companies and updates on the healthcare sector.

Episodes

Under the microscope: Weekly Wrap Week Ending 29 May 2020

8m · Published 28 May 23:27

Healthcare analyst Iain Wilkie runs through a number of healthcare announcements over the week and recaps a few trading ideas which have performed strongly over the last few weeks.

Under the microscope: Volpara Health Technologies (ASX:VHT) - Scott Power, Senior Analyst

2m · Published 19 May 02:22

Scott Power part of the Morgans Healthcare team provides an update on Volpara after successfully completing its capital raising.

Under the microscope: Resmed (ASX:RMD) - Derek Jellinek, Senior Analyst

5m · Published 04 May 02:19

Morgans Senior Analyst Derek Jellinek discusses RMD 3Q results and strong resilience shown across the core business and incremental gains from COVID-19 induced demand for ventilators.

Under the microscope: Weekly Wrap - Week Ending 24 April

6m · Published 24 Apr 01:25

Healthcare analyst Iain Wilkie runs through some market news, a number of updates for stocks under coverage, and some comments on the relaxation of a number of elective medical procedures announced over the week.

Under the microscope: Company Updates - Scott Power, Senior Analyst

6m · Published 20 Apr 00:10

Morgans Senior Analyst Scott Power updates the network with information on 3 companies: Volpara (ASX:VHT), Impedimed (ASX:IPD) and Micro-X (ASX:MX1).

Under the microscope: Opyl (ASX:OPL) - Michelle Gallaher, Chief Executive Officer

6m · Published 09 Apr 03:05

Morgans Research Analyst Iain Wilkie talks with Michelle Gallaher, CEO of Opyl Limited (#ASX : $OPL). Michelle gives a recap on a number of products coming to market, a new partner to expand its reach, and what potential investors can look out for.

Under the microscope: Antisense Therapeutics (ASX:ANP) - Mark Diamond, Managing Director

12m · Published 08 Apr 06:40

Morgans Research Analyst Iain Wilkie talks with Mark Diamond, Managing Director of Antisense Therapeutics (ASX:ANP). Mark shares a recap on what the company does, and what potential investors can look out for.

Under the microscope: Weekly Wrap Week Ending 3 April 2020

4m · Published 03 Apr 02:18

Morgans Senior Analyst Scott Power, close out on the week that was 3/04/2020. He shares an update on the Healthcare sector and run through a couple of stocks to look out for.

Under the Microscope: Weekly Wrap Week Ending 20 March 2020

5m · Published 20 Mar 05:48

Morgans Analyst Iain Wilkie and Senior Analyst Scott Power, close out on the week that was 20/03/2020. They run through another tough week on the market, and provide an update on some of their stocks under coverage.

Under the microscope: Weekly Wrap Week Ending 13 March 2020

5m · Published 13 Mar 04:18

Morgans Analyst Iain Wilkie and Senior Analyst Scott Power, close out on the week that was 13/03/2020. They run through a number of announcements from over the week and share a market wrap on what was one of the sharpest weekly declines in recent years.

Morgans Under the Microscope has 96 episodes in total of non- explicit content. Total playtime is 12:26:38. The language of the podcast is English. This podcast has been added on November 20th 2022. It might contain more episodes than the ones shown here. It was last updated on July 29th, 2023 03:10.